MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT)MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT)MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT)

MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT)

No trades
See on Supercharts

Price target

1.470.000.00%
The 6 analysts offering 1 year price forecasts for 0JYL have a max estimate of — and a min estimate of —.

Analyst rating

Based on 10 analysts giving stock ratings to 0JYL in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


0JYL EPS for the last quarter is −0.42 USD despite the estimation of −0.41 USD. In the next quarter EPS is expected to reach −0.29 USD. Track more of MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) financials and stay on top of what is up with the company.
In the next quarter MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) revenue is expected to reach ‪11.40 M‬ USD. Check out MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) revenue and earnings and make informed decisions.
According to analysts, 0JYL price target is 1.47 USD with a max estimate of 3.00 USD and a min estimate of 0.30 USD. Check if this forecast comes true in a year, meanwhile watch MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) stock price chart and keep track of the current situation with 0JYL news and stock market news.
We've gathered opinions of 10 analysts rating 0JYL stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.